{"id":101441,"date":"2021-04-14T21:59:25","date_gmt":"2021-04-14T16:29:25","guid":{"rendered":"https:\/\/blog.forumias.com\/?p=101441"},"modified":"2021-04-15T08:25:19","modified_gmt":"2021-04-15T02:55:19","slug":"indias-vaccination-strategy-needs-a-course-correction","status":"publish","type":"post","link":"https:\/\/forumias.com\/blog\/indias-vaccination-strategy-needs-a-course-correction\/","title":{"rendered":"India\u2019s vaccination strategy needs a course correction"},"content":{"rendered":"\n

Synopsis: <\/strong>India\u2019s vaccination strategy lacks a few important steps and needs immediate action.<\/p>\n

Introduction:<\/strong> Recently the Drug Controller General of India formally approved another vaccine candidate(Sputnik V<\/a>). This vaccine is approved under emergency use authorisation<\/a>.<\/p>\n

India\u2019s vaccination strategy:<\/strong><\/h5>\n
    \n
  1. So far, India\u2019s vaccination strategy relied almost entirely on Covishield<\/strong>. The other vaccine Covaxin so far has only limited extent in India’s vaccine strategy.<\/li>\n
  2. India also allowed using foreign-made vaccines in India<\/strong>. But, these vaccines have to be approved by their respective regulatory agencies. Such as the U.S., the U.K., Europe, Japan.<\/li>\n
  3. Similarly, there is World Health Organization<\/strong>\u2019s (WHO) list of approved emergency use vaccines. Indians can also use those vaccines.<\/li>\n<\/ol>\n
    Concerns with India\u2019s vaccination strategy:<\/strong><\/h5>\n
      \n
    1. Vaccine approved in a different country may have adverse effects on the Indian population.<\/li>\n
    2. The WHO vaccines can avoid local clinical trials<\/strong>. But, they are subject to parallel bridging trials. For example, Pfizer approached Indian regulators for such bridging trails.<\/li>\n
    3. India due to emergency use authorization rushed through its regulatory process<\/strong>. This is evident as India had enough time and opportunity to conduct clinical trials in the right way for Vaccines such as Covishield and Covaxin.<\/a> But India approved these vaccines under Emergency use.<\/li>\n
    4. Not clear planning on vaccine stocks.\u00a0<\/strong>Countries like the U.K. and the U.S. planned enough vaccine dosage for their country in attaining self-sufficiency. For example, in the US at least 30% of its adults have got one dose of vaccination. But India did not have any such plan. So, without that, \u2018atmanirbhar\u2019 in the vaccine is not feasible.<\/li>\n<\/ol>\n
      Suggestions to improve India’s Vaccine strategy:<\/strong><\/h5>\n

      India\u2019s pharmacovigilance programme has to step up to solve the challenges in India’s vaccine strategy.<\/p>\n

        \n
      1. India must not repeat the same mistake. <\/strong>India has to understand that the available choice of vaccine does not translate into immediate availability.<\/li>\n
      2. All the Indian vaccine companies<\/strong> had a tie-up with their foreign counterparts. So, even though they make millions of vaccines in India, they will sell them to the highest global bidders<\/strong>(Profit-motive).\u00a0 So India has to ensure vaccine availability to at least for its adult population.<\/li>\n
      3. India has to study the past<\/strong>. Last year, the Indian health system faced a shortage of hospital beds, ventilators, and black marketing of drugs. With the cases increasing once again, India has to improve the situation prior to the worrying state.<\/li>\n<\/ol>\n

        Source:<\/strong> The Hindu<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

        Synopsis: India\u2019s vaccination strategy lacks a few important steps and needs immediate action. Introduction: Recently the Drug Controller General of India formally approved another vaccine candidate(Sputnik V). This vaccine is approved under emergency use authorisation. India\u2019s vaccination strategy: So far, India\u2019s vaccination strategy relied almost entirely on Covishield. The other vaccine Covaxin so far has… Continue reading India\u2019s vaccination strategy needs a course correction<\/span><\/a><\/p>\n","protected":false},"author":10311,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":""},"categories":[1230,9],"tags":[1289],"class_list":["post-101441","post","type-post","status-publish","format-standard","hentry","category-9-pm-daily-articles","category-public","tag-soc_0","entry"],"jetpack_featured_media_url":"","views":{"total":0,"cached_at":"","cached_date":1704855286},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts\/101441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/users\/10311"}],"replies":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/comments?post=101441"}],"version-history":[{"count":0,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts\/101441\/revisions"}],"wp:attachment":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/media?parent=101441"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/categories?post=101441"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/tags?post=101441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}